Screener
MBX Biosciences, Inc. MBX Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $555K.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
FAQ
- What is MBX Biosciences, Inc.'s total debt?
- MBX Biosciences, Inc. (MBX) reported total debt of $555K in Q1 2026.
- How has MBX Biosciences, Inc.'s total debt changed year-over-year?
- MBX Biosciences, Inc.'s total debt increased by 326.9% year-over-year, from $130K to $555K.
- What is the long-term trend for MBX Biosciences, Inc.'s total debt?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s total debt has grown at a 35.6% compound annual growth rate (CAGR), from $324K to $596K.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about MBX Biosciences, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude